The ICMR has funded the IPIROC study to evaluate a cost-effective dosing strategy for PARP inhibitor rucaparib in ovarian cancer patients, aiming to enhance access and reduce side effects.

A recent study by The George Institute and Imperial College London highlights the exclusion of women from heat adaptation ...

Arogya World honored 41 organizations for outstanding employee wellbeing initiatives at the 2025 Global Summit, emphasizing ...

Israeli and Dutch researchers develop FibrilPaint and FibrilRuler to measure Tau amyloid fibrils in real-time, potentially revolutionizing Alzheimer's diagnostics and drug development.

AIIMS New Delhi successfully led India's first clinical trial of the Supernova stent retriever, demonstrating effective and ...

The Rajendra Institute of Medical Sciences (RIMS) building is in a state of severe disrepair, causing safety concerns for patients and staff. Immediate attention is required as structural issues ...

AIIMS New Delhi successfully conducted India's first clinical trial for an indigenously developed advanced stroke device, the ...

A comprehensive study conducted by AIIMS, New Delhi reveals no evidence connecting COVID-19 vaccination to sudden deaths in ...

India is positioning itself as a global leader in the intersection of artificial intelligence and traditional medicine ...

Afghan Health Minister Mawlawi Noor Jalal Jalali is set to visit India next week, marking the third ministerial-level trip from Kabul in recent months. This trip aims to enhance healthcare cooperation ...

The Asian Development Bank (ADB) has approved a $108 million results-based loan to support the Government of Mizoram in ...

The World Bank has approved a $305 million funding package for the Haryana Clean Air Project, aiming to achieve ...